Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helena Slaets

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Journal of Neuroimmunology|September 6, 2008
Leukemia inhibitory factor modulates production of inflammatory mediators and myelin phagocytosis by macrophagesJerome J A Hendriks, Helena Slaets, Sofie Carmans, et al.
Glia|April 30, 2015
Oncostatin M protects against demyelination by inducing a protective microglial phenotypeKris Janssens, Anurag Maheshwari, Chris Van den Haute, et al.
Mediators of Inflammation|July 3, 2013
Local overexpression of interleukin-11 in the central nervous system limits demyelination and enhances remyelinationAnurag Maheshwari, Kris Janssens, Jeroen Bogie, et al.
Brain, Behavior, and Immunity|December 17, 2014
Leukemia inhibitory factor tips the immune balance towards regulatory T cells in multiple sclerosisKris Janssens, Chris Van den Haute, Veerle Baekelandt, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 20, 2020
Oncostatin M-induced astrocytic tissue inhibitor of metalloproteinases-1 drives remyelinationEvelien Houben, Kris Janssens, Doryssa Hermans, et al.
The Lancet. Gastroenterology & Hepatology|August 6, 2021
Efficacy and safety of spore-forming probiotics in the treatment of functional dyspepsia: a pilot randomised, double-blind, placebo-controlled trialLucas Wauters, Helena Slaets, Kim De Paepe, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|January 28, 2026
Peripheral Immune Remodeling After Spinal Cord Injury: Marked by Expansion of CD38<sup>+</sup>, CTLA-4<sup>+</sup>, and PD-1<sup>+</sup> T and NK CellsNaomi Veeningen, Ana Laura Añé-Kourí, Astrid Pues, et al.
Acta Neuropathologica|June 6, 2022
Oncostatin M triggers brain inflammation by compromising blood-brain barrier integrityDoryssa Hermans, Evelien Houben, Paulien Baeten, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Journal of Neuroimmunology|September 6, 2008
Leukemia inhibitory factor modulates production of inflammatory mediators and myelin phagocytosis by macrophagesJerome J A Hendriks, Helena Slaets, Sofie Carmans, et al.
Glia|April 30, 2015
Oncostatin M protects against demyelination by inducing a protective microglial phenotypeKris Janssens, Anurag Maheshwari, Chris Van den Haute, et al.
Mediators of Inflammation|July 3, 2013
Local overexpression of interleukin-11 in the central nervous system limits demyelination and enhances remyelinationAnurag Maheshwari, Kris Janssens, Jeroen Bogie, et al.
Brain, Behavior, and Immunity|December 17, 2014
Leukemia inhibitory factor tips the immune balance towards regulatory T cells in multiple sclerosisKris Janssens, Chris Van den Haute, Veerle Baekelandt, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 20, 2020
Oncostatin M-induced astrocytic tissue inhibitor of metalloproteinases-1 drives remyelinationEvelien Houben, Kris Janssens, Doryssa Hermans, et al.
The Lancet. Gastroenterology & Hepatology|August 6, 2021
Efficacy and safety of spore-forming probiotics in the treatment of functional dyspepsia: a pilot randomised, double-blind, placebo-controlled trialLucas Wauters, Helena Slaets, Kim De Paepe, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|January 28, 2026
Peripheral Immune Remodeling After Spinal Cord Injury: Marked by Expansion of CD38<sup>+</sup>, CTLA-4<sup>+</sup>, and PD-1<sup>+</sup> T and NK CellsNaomi Veeningen, Ana Laura Añé-Kourí, Astrid Pues, et al.
Acta Neuropathologica|June 6, 2022
Oncostatin M triggers brain inflammation by compromising blood-brain barrier integrityDoryssa Hermans, Evelien Houben, Paulien Baeten, et al.
Pageof 2